Associated Papers
Effect of drug resistance mutations on antiviral agents in HCV patients.
Liu G et al.
Antiviral Therapy, 2016
Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely observed in DAA-naive patients prior to treatment.
Bartels DJ et al.
Journal of Virology, 2013
Hepatitis C virus nucleotide inhibitors PSI-352938 and PSI-353661 exhibit a novel mechanism of resistance requiring multiple mutations within replicon RNA.
Lam AM et al.
Journal of Virology, 2011
Select a paper to view details